CAS No.: 2921-57-5 Formula: C26H34O8 Molecular Weight: 474.54300
6α-Methylprednisolone 21-Hemisuccinate is a derivative of methylprednisolone, a glucocorticoid and a anti-inflammatory drug used to treat central nervous system disorders such as multiple sclerosis. 6α-Methylprednisolone 21-Hemisuccinate was examined for potential therapeutic efficacy in a model of neuroinflammation in rats with acute autoimmune encephalomyelitis.
Chemical Name | Methylprednisolone sodium hemisuccinate |
Synonyms | Urbason-Soluble; methylprednisolone 21-hemisuccinate; 6-methylprednisolone-21-hemisuccinate; methylprednisolone hemisuccinate esters; Methylprednisolone hydrogen succinate; 4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid; METHYLPREDNISOLONE HEMISUCCINATE; Solumedrol; EINECS 220-863-9; UNII-5GMR90S4KN; METHYLPREDNISOLONE SODIUM SUCCINATE; methylprednisolone succinate; |
CAS No. | 2921-57-5 |
Molecular Formula | C26H34O8 |
Molecular Weight | 474.54300 |
PSA | 138.20000 |
LogP | 2.21930 |
Density | 1.33g/cm3 |
Boiling Point | 689.6ºC at 760mmHg |
Flash Point | 230.7ºC |
Refractive Index | 1.593 |
Vapor Pressure | 5.28E-22mmHg at 25°C |
4-[[(6S,8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]oxy]-4-oxobutanoic acid→Meprednisone+Methylprednisolone sodium hemisuccinate
4-[[(6S,8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]oxy]-4-oxobutanoic acid→Methylprednisolone sodium hemisuccinate
4-[[(6S,8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]oxy]-4-oxobutanoic acid
Meprednisone
4-[[(6S,8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]oxy]-4-oxobutanoic acid